Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 605-140-1 | CAS number: 158237-07-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 7 - 29 March 1995
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Version / remarks:
- adopted 12 May 1981
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: EG Guideline 92/69/EWG. Journal of the European Community - Legal Specifications L 2383 A, 35.
- Version / remarks:
- 29 December 1992
- Qualifier:
- according to guideline
- Guideline:
- other: U.S. Environmental Protection Agency. Pesticide assessment guidelines, subdivision F, hazard evaluation: Human and domestic animals (Revised) § 81-3 Acute Inhalation Toxicity Study. NTIS Report PB86-108958, Washington, DC
- Version / remarks:
- 1984
- Qualifier:
- according to guideline
- Guideline:
- other: U.S. Environmental Protection Agency. Hazard evaluation division: Standard evaluation procedure, inhalation toxicity testing, NTIS Report PB89-100366, Washington, DC.
- Version / remarks:
- 1988
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- 4-(2-chlorophenyl)-N-cyclohexyl-N-ethyl-5-oxo-4,5-dihydro-1H-1,2,3,4-tetrazole-1-carboxamide
- EC Number:
- 605-140-1
- Cas Number:
- 158237-07-1
- Molecular formula:
- C16H20ClN5O2
- IUPAC Name:
- 4-(2-chlorophenyl)-N-cyclohexyl-N-ethyl-5-oxo-4,5-dihydro-1H-1,2,3,4-tetrazole-1-carboxamide
1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- Hsd Win:WU
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann GmbH, Borchen, Germany
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 2 - 3 months
- Weight at study initiation: 170 - 205 g (males), 169 - 187 g (females)
- Housing: individually in Makrolon cages type II during the acclimation and study periods
- Diet: Altromin® 1324 diet, ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2.0
- Humidity (%): approximately 50
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: test substance was aerosolized as dust without a carrier or vehicle
- Mass median aerodynamic diameter (MMAD):
- ca. 2.6 µm
- Geometric standard deviation (GSD):
- ca. 2
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Plexiglas exposure tubes (TSE, Bad Homburg, Germany)
- Exposure chamber volume: 3.8 L (dimensions of the inhalation chamber: inner diameter =14 cm, outer diameter = 35 cm (two-chamber system), height = 25 cm)
- Source and rate of air: compressed air supplied by Boge compressors
- Method of conditioning air: automatically by a VIA compressed air dryer
- System of generating particulates/aerosols: In order to obtain the high concentration of respirable aerosol an EXACTOMAT 4200 (TSE, 61348 Bad Homburg, Germany) and for the lower concentration a wright-dust-feeder (BGI Inc., Waltham, MA, USA) was used.
- Method of particle size determination: gravimetric analyses (cascade impactors)
- Treatment of exhaust air: the exhaust air was purified via cotton-wool/activated charcoal and HEPA filters. These filters were disposed of.
- Temperature, humidity, pressure in air chamber: 22°C, humidity: control group: 15%, 535 mg/m³: 8% and 5085 mg/m³: 4%
TEST ATMOSPHERE
- Brief description of analytical method used: gravimetric analysis with cellulose-acetate filter
- Samples taken from breathing zone: yes
- Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- 535 mg/m³
5085 mg/m³ - No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 and 28 days
- Frequency of observations and weighing: clinical signs: several times on the day of exposure and at least once daily thereafter; body weights: measured prior to exposure and on Day 3 and 7 and weekly thereafter
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight, gross pathology - Statistics:
- Statistically significant differences (vs control) are indicated by asterisks (*for p < 0.05, **for p < 0.01).
Necropsy: evaluation of respiratory tract findings in surviving rats(pairwise Fisher test after the RxC chi-squared test) The Fisher test was only performed if differences occurred between groups in the RxC chi-squared test or if a frequency value of < 5 was calculated (according to with Gad and Weil, 1982). For calculation of the unilateral p value a symmetrical distribution was assumed (p unilateral = (p bilateral)/2).
Body weights: Means and single standard deviations of body weights are calculated. Since in acute studies individual group means may differ prior to commencement of the first exposure, the body weight gain was statistically evaluated for each group (one-way ANOVA (vide infra))
Physical measurements: means + single standard deviation
Physiological data: rectal temperature measurements (ANOVA (vide infra))
Calculation of the LC50: according to the method of A.P. Rosiello et al (1977) as modified by Pauluhn (1983) (based on the maximum-likelihood method of C.I. Bliss (1938)). If only 2 pairs of values with greater than 0% lethality and less than 100% are available then the first linear approximation is based on these values and a x²-homogeneity test is not performed. The interpolated concentration at 50% lethality in this case was designated the approximate LC50.
Randomization: computerized list of random numbers (animals)
Analysis of variance (ANOVA): groups are compared at a confidence level of (1-oc) = 95% (p = 0.05). The test for the between-group homogeneity of the variance employed Box's test if more than 2 groups were compared. If the F-test shows that the intra-group variability> inter-group variability, this is shown as "no statistical difference between the groups". If a difference is found then a pairwise post-hoc comparison is conducted (1- and 2-sided) (Games and Howell modification of the Tukey-Kramer significance test)
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5 085 mg/m³ air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No mortality occured until the end of the observation period.
- Clinical signs:
- other: All rats tolerated the treatment without any clinical sign.
- Body weight:
- Decreased body weights were determined in both treatment groups. However, these changes were minor and transient in nature and are therefore considered to be toxicologically insignificant.
- Gross pathology:
- No findings related to treatment were observed.
- Other findings:
- Rectal temperature:
Statistical comparison between groups exposed to the test substance with those in the control group did indicate concentration-dependent effect on body temperature in all groups exposed to the test compound. The changes observed, however, are considered to be toxicologically insignificant.
Any other information on results incl. tables
Aerosol generation:
The aerosol generated was of adequate respirability in the lower exposure group (i.e. MMAD ca. 2.6 |um, GSD ca. 2, relative mass < 3 \im ca. 60%). It appeared not to be feasible to generate concentrations approximating 5000 mg/m³ air using a cyclone to seperate off larger particles. This, in fact, resulted in a decreased respirability of particles in the highest esposure group. Despite the lower respirability rats experienced a hypothermia in the higher exposure groups.
Table 2: Summary of acute inhalation
Group/Sex |
Gravimetric Concentration (mg/m³) |
Toxicological Result |
Onset and duration of signs |
Rectal temperature (°C) |
Onset of Mortality
|
1/m |
0 |
0/0/5 |
- |
38.2 |
- |
2/m |
535 |
0/0/5 |
- |
37.3** |
- |
2/m |
5085 |
0/0/5 |
- |
35.8** |
- |
1/f |
0 |
0/0/5 |
- |
38.6 |
- |
2/f |
535 |
0/0/5 |
- |
37.0** |
- |
3/f |
5085 |
0/0/5 |
- |
35.4** |
- |
m = males, f = females, — not applicable
Values given in the 'Toxicological results' column are:
1st = number of dead animals.
2nd = number of animals with signs after cessation of exposure.
3rd = number of animals exposed.
Table 3: Mean Bodyweights with standard deviations [g]
Dose [mg/m3] |
Sex |
exposure day |
3 days after exposure |
1 week after exposure |
2 weeks after exposure |
control |
m |
197.2 ± 5.1 |
202 ± 4.6 |
221.0 ± 6.3 |
254.8 ± 9,5 |
535 |
m |
170.8 ± 1.3 |
177 ± 4.4 |
204.4 ± 5.9 |
239.4 ± 9.5 |
5085 |
m |
192.6 ± 6.2 |
200.6 ± 8.4 |
224.2 ± 10.0 |
255.0 ± 10.6 |
control |
f |
185.2 ± 1.5 |
184.0 ± 2.5 |
187.2 ± 2.5 |
198.2 ± 5.6 |
535 |
f |
171.6 ± 2.9 |
167.0 ± 7.6 |
174.8 ± 7.5 |
185 ± 8.0 |
5085 |
f |
178.2 ± 4.4 |
174.6 ± 6.3 |
176.8 ± 6.9 |
188.4 ± 7.3 |
m male, f female
Table 4: Gross pathology findings
Group |
Dose [mg/m3] |
Animals with effects |
Time of death |
Sacrificed after |
Pathology findings |
1 m |
control |
0/5 |
- |
28 days |
no observable effects |
2 m |
535 |
1/5 |
- |
14 days |
lung: foci slightly dark red |
3 m |
5085 |
0/5 |
- |
14 days |
no observable effects |
1 f |
control |
0/5 |
- |
28 days |
no observable effects |
2 f |
535 |
0/5 |
- |
14 days |
no observable effects |
3 f |
5085 |
0/5 |
- |
14 days |
no observable effects |
m male, f female
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria are not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- In this acute inhalation toxicity study in rats a LC50 value of > 5085 mg/m³ air was determined.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.